Cipla's arm Meditab sells stake in Jiangsu for $18.5 million - (Business Standard via NewsPoints Desk)

  • Cipla's subsidiary in Mauritius, Meditab Holdings, signed a deal to sell its 48.22 percent stake in Cdymax Pharmaceuticals for $18.5 million, as reported Wednesday in Business Standard.
  • The closing of the transaction is subject to receipt of applicable regulatory approvals in China, the company added.

To read more NewsPoints articles, click here.

Reference Articles